Published in Acta Anaesthesiol Sin on September 01, 1995
Obstructive sleep apnea, pain, and opioids: is the riddle solved? Curr Opin Anaesthesiol (2016) 0.77
Postoperative pain management among surgically treated patients in an Ethiopian hospital. PLoS One (2014) 0.75
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med (1988) 8.90
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst (1994) 7.20
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA (1994) 6.36
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother (2001) 5.83
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med (1990) 5.27
The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J (2000) 4.82
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg (1998) 4.35
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg (1989) 3.58
Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med (1997) 3.07
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol (1999) 2.94
Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology (1999) 2.63
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J Natl Cancer Inst (1998) 2.17
The large subunit of RNA polymerase II is a substrate of the Rsp5 ubiquitin-protein ligase. Proc Natl Acad Sci U S A (1997) 2.09
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol (1989) 2.00
Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol (1987) 1.96
Lethal injuries and time to death in a level I trauma center. J Am Coll Surg (1998) 1.94
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst (1993) 1.91
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma. Cancer J Sci Am (2006) 1.89
The diposi tion of morphine in surgical patients. Clin Pharmacol Ther (1975) 1.83
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol (1999) 1.78
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res (1995) 1.76
Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. Cancer Res (2001) 1.74
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J Immunol (1999) 1.71
Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Cancer J Sci Am (1998) 1.68
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol (1990) 1.59
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene (2008) 1.57
Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys (1991) 1.53
Percutaneous trans-hepatic cholangioscopy and lithotripsy in the treatment of intrahepatic stones: a study with 5 year follow-up. Gastrointest Endosc (1995) 1.50
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy. J Immunother Emphasis Tumor Immunol (1994) 1.49
Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr (2000) 1.49
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. J Clin Oncol (1992) 1.48
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J Immunother (1997) 1.47
In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst (1989) 1.46
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol (1989) 1.46
Pancreatic tuberculosis with obstructive jaundice--a case report. Am J Gastroenterol (1999) 1.44
Effect of a compensated Jaffe creatinine method on the estimation of glomerular filtration rate. Ann Clin Biochem (2004) 1.44
Solution to the dilemma of retrieving an endoscope from the esophagus. Gastrointest Endosc (1999) 1.38
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol (1993) 1.37
Treatment of hirsutism with spironolactone. JAMA (1982) 1.34
In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst (1987) 1.31
Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis. Virchows Arch (2001) 1.30
Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology (1976) 1.26
Follicular dendritic cell tumor of the liver: a clinicopathologic and Epstein-Barr virus study of two cases. Mod Pathol (2001) 1.26
RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther (1996) 1.24
Macronodular multi-organs tuberculoma: CT and MR appearances. J Gastroenterol (1998) 1.21
Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions. J Vasc Interv Radiol (2001) 1.20
Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer (2001) 1.18
Control of shivering under regional anesthesia in obstetric patients with tramadol. Can J Anaesth (1999) 1.17
Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori. Biochem Biophys Res Commun (1997) 1.16
Stereoisomeric Characterization of Tartaric Acid Produced during l-Ascorbic Acid Metabolism in Plants. Plant Physiol (1975) 1.12
Using the modified Delphi method to establish a new Chinese clinical consensus of the treatments for cervical radiculopathy. Eur Spine J (2015) 1.12
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol (2001) 1.11
Correlations between cadmium and mineral nutrients in absorption and accumulation in various genotypes of rice under cadmium stress. Chemosphere (2003) 1.11
Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells. J Immunol (1986) 1.11
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J Immunol (1996) 1.10
Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component. Mod Pathol (2001) 1.09
Extending the limit on the size of adult recipient in living donor liver transplantation using extended right lobe graft. Transplantation (1997) 1.09
Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place. J Urol (1999) 1.07
Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation (1996) 1.07
Detection of Helicobacter pylori in gastric biopsy tissue by polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1993) 1.06
Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors. Cancer Res (1988) 1.05
Immunization against endogenous retroviral tumor-associated antigens. Cancer Res (2001) 1.05
Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction. Arch Biochem Biophys (2001) 1.04
Sequential 1H NMR assignments and secondary structure of an IgG-binding domain from protein G. Biochemistry (1991) 1.03
Antagonism of nitrous oxide analgesia by naloxone in man. Anesthesiology (1980) 1.03
Clinical implications of neuroendocrine differentiation in prostate cancer. Prostate Cancer Prostatic Dis (2006) 1.03
Prostatic stromal sarcoma in a young adult: a case report. Arch Androl (2005) 1.01
Colvalent linkage of phospholipid to myelin basic protein: identification of phosphatidylinositol bisphosphate as the attached phospholipid. Biochemistry (1986) 1.01
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. J Formos Med Assoc (1998) 1.01
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. Cancer Res (1996) 1.00
Determination of the solution structures of domains II and III of protein G from Streptococcus by 1H nuclear magnetic resonance. J Mol Biol (1992) 1.00
Biosynthesis and metabolism of ascorbic acid in plants. Ann N Y Acad Sci (1975) 1.00
Analgesic action and pharmacokinetics of morphine and diazepam in man: an evaluation by sensory decision theory. Anesthesiology (1979) 0.97
Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy. Int J Radiat Oncol Biol Phys (1993) 0.96
Conformation and ion-channeling activity of a 27-residue peptide modeled on the single-transmembrane segment of the IsK (minK) protein. Biochemistry (1998) 0.96
Solution structure of a C-terminal coiled-coil domain from bovine IF(1): the inhibitor protein of F(1) ATPase. J Mol Biol (2001) 0.96
The development of gene therapy for the treatment of cancer. Ann Surg (1993) 0.95
Transcholecystic endoscopic choledocholithotripsy: successful management of retained common bile duct stone. Endoscopy (1987) 0.94
Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev (2003) 0.94
Metal-molecule contacts and charge transport across monomolecular layers: measurement and theory. Phys Rev Lett (2002) 0.94
Sequence-specific resonance assignment and conformational analysis of subtilin by 2D NMR. FEBS Lett (1992) 0.93
Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. Pediatr Infect Dis J (2001) 0.93
The interactions of Escherichia coli trp repressor with tryptophan and with an operator oligonucleotide. NMR studies using selectively 15N-labelled protein. Eur J Biochem (1994) 0.92
Understanding charge transport in molecular electronics. Ann N Y Acad Sci (2003) 0.92
Clinical application of IL6 in cancer therapy. Res Immunol (1992) 0.92
A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses. Surgery (1992) 0.92
An audit of the safety of an acute pain service. Anaesthesia (1997) 0.91
Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma. Cancer Lett (1998) 0.91
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res (2000) 0.91
Percutaneous transhepatic choledochoscopic electrohydraulic lithotripsy (PTCS-EHL) of common bile duct stones. Gastrointest Endosc (1988) 0.91
Maxillary amelanotic melanoma: a case report. J Oral Maxillofac Surg (2001) 0.90
The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma. Cancer (1995) 0.90
Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res (1993) 0.90
Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses. Cancer Res (1995) 0.90
Structural and dynamic studies of a non-self-complementary dodecamer DNA duplex. Nucleic Acids Res (1993) 0.89
Five-year experience with the development of a liver transplant program in Hong Kong. Transplant Proc (1998) 0.89